Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

计划入组 150 人 · 首次发布于 2007 年 11 月 8 日

Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database

计划入组 54,459 人 · 首次发布于 2011 年 6 月 27 日

Endothelial Microparticles as Potential Biomarkers of Endothelial Dysfunction

计划入组 48 人 · 首次发布于 2020 年 8 月 13 日

Glycinamide Ribonucleotide

C₇H₁₅N₂O₈P

AICA ribonucleotide

C₉H₁₅N₄O₈P

Lipo-4MA (AntiCancer Inc)

Corvus Pharmaceuticals

United States

Kura Oncology

United States

Odyssey Therapeutics

Phase 2 Trial Shows 70% Response Rate for Novel Combination Therapy in Advanced Neuroendocrine Tumors

Nanopharmaceutics Completes Enrollment in Phase 2 Neuroendocrine Tumor Study Combining Triapine with Lutetium Lu 177 Dotatate

Nanopharmaceutics Completes Phase II Enrollment for Triapine Combination Therapy in Neuroendocrine Tumors